Lasianthera africana Beauv.
Introduction
Crop plants generally represent an extraordinary reservoir of novel molecules. However, hundreds of thousands of metabolites may be present in medicinal crop plant. There is currently a resurgence of interest in the use of vegetables as a possible source of new lead compounds for therapeutic screening (Hostettma et al., 1997) . Lasianthera africana Beauv. (Aquifoliales: Stemonuraceae) is a vegetable crop which has promising potentials for curative uses. It is commonly known as "editan" in Efik and Ibibio communities of Akwa Ibom and Cross River States. It is monospecific genus located in South Eastern Nigeria and extending towards Camerouns (Bassey et al., 2004) . They are used in traditional concoction for the treatment of constipation, stomach aches/ulcer and prevention of miscarriage in pregnant women (Sofowora, 1993) . Folklore information revealed that the decoction of the plant is used as a remedy for internal heat as well as antihelmintic agent. Chatterjee (1963) reported that bitter principles from plants were associated with management and control of diabetes mellitus. Prevalence of diabetes in some countries has risen up to 1% to 2% of the population with African countries on the increase (Barnett, 1991) . It is estimated that about 140 million people worldwide are affected by diabetes and it is quite shocking to note that in our teeming population almost one million Nigerians are suffering from this traumatic disease (Ike, 2001) .
Despite considerable progress in the management of diabetes mellitus by conventional synthetic drugs, the search for natural anti-diabetic plant for the control of diabetes is crucial. This calls for the evaluation of the therapeutic potential of L. africana leaf in the control and management of diabetes mellitus using experimentally induced diabetic rats.
Materials and methods

Plant material
L. africana leaves were collected from Essien Udim Local Government Area of Akwa Ibom State, Nigeria.
Extraction and analysis 600 g each of ground air-dried leaf sample were extracted with 70% of ethanol at room temperature while aqueous extraction was carried out with the cold extraction method. The extracts were concentrated under pressure to yield 46.0 g and 28.0 g ethanol and aqueous extract, respectively.
Phytochemical analysis
Phytochemical screening of the leaf was conducted on the two extracts according to the methods described by Trease and Evans (2002) . All experimental procedures for phytochemical screening were replicated 3 times to establish the reproducibility of the extract.
Experimental animals
Twenty-four (24) male albino rats of body weight range of 120-200 g were purchased from Animal Unit of The Department of Pharmacology and Toxicology, University of Uyo, Uyo, Nigeria. The rats had access to pellets (product of Feeds Grower Nigeria Ltd.) and drinking water before they were fasted overnight.
Diabetes induction
The animals were fed with standard pellet and after 12 h fasting overnight, the animals were made to be diabetic by a single dose of alloxan (150 mg/kg) administered as 5% w/v in distilled water injected by intraperitoneal (i.p) route. Diabetes developed after 72 h and confirmation was carried out by testing glucosuria using indicator sticks (Bayer Diagnostics Basingstoke, UK). Rats with fasting blood sugar at 200 mg/dL and above were considered diabetic (Gidado et al., 2005) .
Hypoglycaemic evaluation
The 24 experimental rats were divided into four groups with six animals per group. Group 1 served as normal control and received (1 mL) distilled water; Group 2 received 500 mg/kg, 1,000 mg/kg and 1,500 mg/kg of ethanolic extract and Group 3 received 500 mg/kg, 1,000 mg/kg, 1,500 mg/kg of aqueous extract, respectively. Group 4 received 10 mg/kg of reference control drug Daonil (glibenclamide) (Resmi et al., 2001; Ghosh et al. 2004 ). Blood samples were collected between and after treatments.
Toxicity
The LD 50 of the extract was done on the rats by oral and intraperitoneal (i.p) route using the method of Dietrich (1983). In the first phase, 24 male albino rats randomly divided into four groups of six rats per group were given 500, 1,000, 1,500 mg extract/kg body weight orally (via a cannula), respectively. The rats were observed for signs of adverse effects and death for 24 h and then weighed daily for 14 days. In the second phase of the study, the procedure was repeated using six rats randomly divided into four groups each given 500, 1,000, 1,500 mg extract/kg body weight intraperitoneally. The rats were also observed for signs of toxicity, mortality and weighed for 14 days.
Statistical analysis
Statistical analysis were performed by ANOVA, using SPSS (Naggar, 2005) .
Results and discussion
Phytochemical screening revealed the presence of alkaloids, philobatannis, flavonoids, glycosides, terpenes, tannins and saponnins (Table 1 ). This shows that Lasianthera africana contains important class of bioactive substances, frequently employed as starting material for the synthesis of some useful drugs. The Table 1 . Qualitative phytochemical screening result of aqueous and ethanolic leaf extracts of L. africana. hypoglycaemic studies as shown with the ethanolic and aqueous extracts of the plant significantly lowered blood sugar levels (p < 0.05) which compared favourably with the synthetic reference drug. This study implies that L. africana leaf possesses adequate anti-diabetic properties which may be useful for diabetic patients in the management and control of this complex disorder (Table 2 and Figure 1 ). This study corroborates with the findings of Delfan et al. (2014) who reported that anti-diabetic herbs have phytochemicals that can inhibit facilitated diffusion and glucose uptake through active transportation. The decrease in blood sugar could be beneficial in preventing diabetic complications as well as improving lipid metabolism in diabetic patients (Cho et al., 2002) . Toxicity results showed that the leaf is non-toxic and confirmed its safety for consumption (Etukudo, 2003 ) (see Table 3 and 4). 
Conclusion
The study has established for the first time, that Lasianthera africana leaf possesses hypoglycaemic and antihyperglycaecmic properties and could serve as anti-diabetic regimen. It also validates the claims of the plant's use as an antidiabetic supplement. It is necessary for researchers to find out the active substances responsible for hypoglycaemic activity, so that it would be possible to produce drugs which are useful in management and control of diabetes.
